STC Biologics is a Cambridge-based biotechnology company focused on the development of biologic drugs. Magdalena Leszczyniecka, the company's president and CEO, launched the business just as the market crashed. After several years in the field, Leszczyniecka shared her experiences with bartering, negotiating, and asking for help.